Gary Taylor
Stock Analyst at TD Cowen
(3.51)
# 933
Out of 4,650 analysts
145
Total ratings
54.17%
Success rate
3.26%
Average return
Main Sectors:
Stocks Rated by Gary Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Maintains: Buy | $450 → $440 | $360.67 | +22.00% | 9 | Oct 28, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $601 → $609 | $562.13 | +8.34% | 4 | Oct 18, 2024 | |
| HUM Humana | Downgrades: Hold | $402 → $261 | $257.77 | +1.25% | 19 | Oct 7, 2024 | |
| ALHC Alignment Healthcare | Maintains: Buy | $8 → $10 | $11.71 | -14.60% | 5 | Aug 6, 2024 | |
| CNC Centene | Maintains: Buy | $80 → $89 | $60.62 | +46.82% | 10 | Jul 31, 2024 | |
| MOH Molina Healthcare | Maintains: Buy | $351 → $378 | $323.13 | +16.98% | 18 | Jul 29, 2024 | |
| UHS Universal Health Services | Maintains: Hold | $183 → $220 | $205.92 | +6.84% | 12 | Jul 26, 2024 | |
| DVA DaVita | Maintains: Hold | $139 → $150 | $158.31 | -5.25% | 11 | Jul 24, 2024 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $101 → $91 | $51.60 | +76.36% | 3 | May 17, 2024 | |
| BBWI Bath & Body Works | Maintains: Outperform | $35 → $55 | $28.84 | +90.71% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $26 | $17.97 | +44.69% | 5 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $6.5 | $2.52 | +157.94% | 3 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $39 → $35 | $30.06 | +16.43% | 2 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $84 → $101 | $95.33 | +5.95% | 3 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $564 → $585 | $410.57 | +42.48% | 2 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $0.39 | - | 1 | Jun 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $6 | $15.93 | -62.34% | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $8 | $6.82 | +17.30% | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $242 → $329 | $308.23 | +6.74% | 3 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $7 → $3 | $4.05 | -25.93% | 4 | Feb 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $420 | $1.53 | +27,350.98% | 1 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $5.90 | +188.14% | 1 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $28 → $20 | $162.76 | -87.71% | 12 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $20 | $12.97 | +54.20% | 6 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $4.09 | - | 6 | Dec 14, 2017 |
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450 → $440
Current: $360.67
Upside: +22.00%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601 → $609
Current: $562.13
Upside: +8.34%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $402 → $261
Current: $257.77
Upside: +1.25%
Alignment Healthcare
Aug 6, 2024
Maintains: Buy
Price Target: $8 → $10
Current: $11.71
Upside: -14.60%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80 → $89
Current: $60.62
Upside: +46.82%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351 → $378
Current: $323.13
Upside: +16.98%
Universal Health Services
Jul 26, 2024
Maintains: Hold
Price Target: $183 → $220
Current: $205.92
Upside: +6.84%
DaVita
Jul 24, 2024
Maintains: Hold
Price Target: $139 → $150
Current: $158.31
Upside: -5.25%
Acadia Healthcare Company
May 17, 2024
Maintains: Buy
Price Target: $101 → $91
Current: $51.60
Upside: +76.36%
Bath & Body Works
Mar 1, 2024
Maintains: Outperform
Price Target: $35 → $55
Current: $28.84
Upside: +90.71%
Mar 1, 2024
Maintains: Outperform
Price Target: $30 → $26
Current: $17.97
Upside: +44.69%
Feb 26, 2024
Downgrades: Market Perform
Price Target: $12 → $6.5
Current: $2.52
Upside: +157.94%
Nov 14, 2023
Upgrades: Outperform
Price Target: $39 → $35
Current: $30.06
Upside: +16.43%
Jul 31, 2023
Maintains: Market Perform
Price Target: $84 → $101
Current: $95.33
Upside: +5.95%
Jul 24, 2023
Maintains: Outperform
Price Target: $564 → $585
Current: $410.57
Upside: +42.48%
Jun 30, 2023
Initiates: Market Perform
Price Target: n/a
Current: $0.39
Upside: -
Feb 14, 2023
Maintains: Market Perform
Price Target: $3 → $6
Current: $15.93
Upside: -62.34%
Nov 14, 2022
Maintains: Outperform
Price Target: $10 → $8
Current: $6.82
Upside: +17.30%
May 9, 2022
Upgrades: Outperform
Price Target: $242 → $329
Current: $308.23
Upside: +6.74%
Feb 2, 2022
Upgrades: Market Perform
Price Target: $7 → $3
Current: $4.05
Upside: -25.93%
Sep 10, 2021
Initiates: Outperform
Price Target: $420
Current: $1.53
Upside: +27,350.98%
Sep 10, 2021
Initiates: Market Perform
Price Target: $17
Current: $5.90
Upside: +188.14%
Sep 21, 2020
Downgrades: Underweight
Price Target: $28 → $20
Current: $162.76
Upside: -87.71%
Feb 24, 2020
Maintains: Neutral
Price Target: $33 → $20
Current: $12.97
Upside: +54.20%
Dec 14, 2017
Downgrades: Underweight
Price Target: n/a
Current: $4.09
Upside: -